NuVasive reported revenue growth in the fourth quarter and full year 2014 financial results.
Here are 10 things to know from the company's financial report:
1. NuVasive reported net income at $20 million on a non-GAAP basis, or $0.39 per share, for the fourth quarter. For the full year, the net income on a non-GAAP basis was $57.5 million, or $1.16 per share. This is relatively flat over 2013.
2. Fourth quarter revenue reached $204.3 million, a 7.1 percent increase over the same period last year. The full year net revenue reached $762.4 million, an 11.3 percent increase over 2013.
3. Full year total revenue was up 11.6 percent on a constant currency basis over 2013.
4. GAAP operating expenses for the fourth quarter was $133.3 million, up slightly over the same period last year. The total GAAP operating expenses for the full year was $561.9 million in 2014, compared to $471.6 million in 2013.
5. Cash, cash equivalents and short and long-term marketable securities were around $405.8 million at Dec. 31, 2014.
6. NuVasive generated $19.1 million in cash flow operations in the fourth quarter. For the full year, the company generated $115.5 million in cash flow from operations.
7. The company invested $12.7 million in capital expenditures. The full year capital expenditure investment was $58.2 million.
8. NuVasive expects revenue to hit around $810 million in 2015, including around $10 million of currency headwinds. This would be a 6 percent growth when compared with 2014.
9. The company expects GAAP earnings per share around $0.67, which is a $0.36 loss per share compared with 2014.
10. NuVasive expects 2015 Non-GAAP operating margin of around 14.4 percent, an increase of around 300 basis points compared to 2014.